Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Exploring mixed phenotype acute leukemia: Clinical, immunophenotypic, cytogenetic, and prognostic insights from a tertiary care center.

Indian journal of pathology & microbiology - 1 Jan 2026

Sarjana, Jasmita, Agarwal Mukul, Ganesh V, Mahapatra Manoranjan

Abstract excerpt

INTRODUCTION: Mixed-phenotype acute leukemias (MPALs) are a rare and aggressive group of leukemias, accounting for approximately 2%-5% of all leukemia cases. MPAL is characterized by the expression of markers from more than one hematopoietic lineage, either myeloid and lymphoid, which can be identified through flow cytometry immunophenotyping. This study aims to describe the clinicopathological, immunophenotypic,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Child
Share to Child, Preschool

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Flow Cytometry

Share to Immunophenotyping

Share to Leukemia

Share to Prognosis

Share to Tertiary Care Centers

Share to Young Adult

Source

Identifiers

PMID: 41913419
DOI: 10.4103/ijpm.ijpm_301_25

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Exploring mixed phenotype acute leukemia: Clinical, immunophenotypic, cytogenetic, and prognostic insights from a tertiary care center.PMID 41913419Read ↗

Mixed-phenotype acute leukemia: state-of-the-art of the diagnosis, classification and treatment.Semantic proximity Read ↗

Mixed Phenotype/Lineage Leukemia: Has Anything Changed for 2021 on Diagnosis, Classification, and Treatment?Semantic proximity Read ↗

An update on classification, genetics, and clinical approach to mixed phenotype acute leukemia (MPAL).Semantic proximity Read ↗

Mixed-phenotype acute leukemia: current challenges in diagnosis and therapy.Semantic proximity Read ↗

Mixed-Phenotype Acute Leukemia: Diagnostic Criteria and PitfallsSemantic proximity Read ↗

Mixed-Phenotype Acute Leukemia: Clinical Diagnosis and Therapeutic StrategiesSemantic proximity Read ↗

Cytogenetic aberration in mixed-phenotype acute leukemia in children: A single-center retrospective review.Semantic proximity Read ↗

Allogeneic Hematopoietic Stem Cell Transplantation with Myeloablative Conditioning Is Associated with Favorable Outcomes in Mixed Phenotype Acute Leukemia.Semantic proximity Read ↗

Defining 2 biologically and clinically distinct groups in acute leukemia with a mixed phenotypeSemantic proximity Read ↗

Mixed-phenotype acute leukemia: historical overview and a new definition.Semantic proximity Read ↗

Genomic Landscape of Mixed-Phenotype Acute Leukemia.Semantic proximity Read ↗

Mixed phenotype acute leukemia: A study of 61 cases using World Health Organization and European Group for the Immunological Classification of Leukaemias criteria.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.